LifePoint Health Inc. (LPNT)
NASDAQ: LPNT
· Real-Time Price · USD
64.99
0.00 (0.00%)
At close: Jun 29, 2019, 12:07 AM
LifePoint Health Revenue Breakdown
Period Ending | Dec 31, 2013 |
---|---|
Sole Community Provider Program Revenue | 16.3M |
Sole Community Provider Program Revenue Growth | n/a |
Revenue by Geography
Period Ending | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
---|---|---|---|---|---|---|---|
K Revenue | 704.2M | 679.9M | 638.5M | 587.9M | 520.9M | 510.9M | 501.5M |
K Revenue Growth | +3.57% | +6.48% | +8.61% | +12.86% | +1.96% | +1.87% | n/a |
M Revenue | 444.9M | 468M | 476.2M | 460.8M | 345.4M | 299.6M | 291.3M |
M Revenue Growth | -4.94% | -1.72% | +3.34% | +33.41% | +15.29% | +2.85% | n/a |
N Revenue | 345.7M | 320.4M | 287.3M | 266.5M | 256.5M | 375.3M | 345.1M |
N Revenue Growth | +7.90% | +11.52% | +7.80% | +3.90% | -31.65% | +8.75% | n/a |
P Revenue | 553.1M | 562.5M | 566.5M | 404.5M | 394.9M | 413.6M | 369M |
P Revenue Growth | -1.67% | -0.71% | +40.05% | +2.43% | -4.52% | +12.09% | n/a |
T Revenue | 465.3M | 450.1M | 420.7M | 624.4M | 469.2M | n/a | n/a |
T Revenue Growth | +3.38% | +6.99% | -32.62% | +33.08% | n/a | n/a | n/a |
V Revenue | 653.9M | 661.8M | 641.9M | n/a | n/a | n/a | n/a |
V Revenue Growth | -1.19% | +3.10% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
Period Ending | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 136.2M | 133.7M | 131.2M | 122.3M | 135.2M | 132.1M | 130.4M | 130.4M | 136.4M | 134.2M | 151.6M | 109.6M | 108.8M | 103.2M | 101.6M |
Selling, General, and Administrative Revenue Growth | +1.87% | +1.91% | +7.28% | -9.54% | +2.35% | +1.30% | 0.00% | -4.40% | +1.64% | -11.48% | +38.32% | +0.74% | +5.43% | +1.57% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |